108 related articles for article (PubMed ID: 27463204)
1. 2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.
Beutler E; Piro LD; Saven A; Kay AC; McMillan R; Longmire R; Carrera CJ; Morin P; Carson DA
Leuk Lymphoma; 1991; 5(1):1-8. PubMed ID: 27463204
[TBL] [Abstract][Full Text] [Related]
2. 2-Chlorodeoxyadenosine: hairy cell leukemia takes a surprising turn.
Beutler E; Carson DA
Blood Cells; 1993; 19(3):559-68; discussion 569-72. PubMed ID: 8018939
[TBL] [Abstract][Full Text] [Related]
3. On the phosphorylation of 2-chlorodeoxyadenosine (CdA) and its correlation with clinical response in leukemia treatment.
Arnér ES
Leuk Lymphoma; 1996 Apr; 21(3-4):225-31. PubMed ID: 8726403
[TBL] [Abstract][Full Text] [Related]
4. 2-Chlorodeoxyadenosine in haematological malignancies.
Castaigne S
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):13-4. PubMed ID: 8099730
[TBL] [Abstract][Full Text] [Related]
5. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
Carson DA; Wasson DB; Esparza LM; Carrera CJ; Kipps TJ; Cottam HB
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2970-4. PubMed ID: 1348362
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of pentostatin and cladribine in hairy cell leukemia.
Johnston JB
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():43-5. PubMed ID: 21463108
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
Seto S; Carrera CJ; Kubota M; Wasson DB; Carson DA
J Clin Invest; 1985 Feb; 75(2):377-83. PubMed ID: 2579098
[TBL] [Abstract][Full Text] [Related]
8. Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine.
Kawasaki H; Carrera CJ; Piro LD; Saven A; Kipps TJ; Carson DA
Blood; 1993 Feb; 81(3):597-601. PubMed ID: 8094016
[TBL] [Abstract][Full Text] [Related]
9. 2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
Saven A; Piro LD
Leuk Lymphoma; 1993; 11 Suppl 2():109-14. PubMed ID: 7907251
[TBL] [Abstract][Full Text] [Related]
10. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
[TBL] [Abstract][Full Text] [Related]
11. [Cladribine].
Ogura M
Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885
[TBL] [Abstract][Full Text] [Related]
12. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
Begleiter A; Glazer RI; Israels LG; Pugh L; Johnston JB
Cancer Res; 1987 May; 47(9):2498-503. PubMed ID: 3494509
[TBL] [Abstract][Full Text] [Related]
13. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes.
Carson DA; Wasson DB; Taetle R; Yu A
Blood; 1983 Oct; 62(4):737-43. PubMed ID: 6136305
[TBL] [Abstract][Full Text] [Related]
14. Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.
Robak T; Korycka A; Kasznicki M; Wrzesien-Kus A; Smolewski P
Curr Cancer Drug Targets; 2005 Sep; 5(6):421-44. PubMed ID: 16178817
[TBL] [Abstract][Full Text] [Related]
15. 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.
Krykowski E; Warzocha K; Robak T
Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):317-21. PubMed ID: 8744653
[TBL] [Abstract][Full Text] [Related]
16. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
[TBL] [Abstract][Full Text] [Related]
17. Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.
Carson DA; Wasson DB; Beutler E
Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2232-6. PubMed ID: 6585795
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
Begleiter A; Pugh L; Israels LG; Johnston JB
Cancer Res; 1988 Jul; 48(14):3981-6. PubMed ID: 3260129
[TBL] [Abstract][Full Text] [Related]
19. [Subcutaneous therapy of hairy cell leukemia with 2-chlorodeoxyadenosine].
Nielsen OJ; Hippe E; Priø TK; Juliusson G
Ugeskr Laeger; 1994 Apr; 156(16):2407-9. PubMed ID: 7912015
[TBL] [Abstract][Full Text] [Related]
20. Cladribine in the treatment of chronic lymphocytic leukemia.
Robak T
Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
